A newly engineered antibody can penetrate kidney cysts and interrupt the growth signals that drive polycystic kidney disease.
That's what 61-year-old retiree Christine Chia has had to grapple with since she was diagnosed with polycystic kidney disease ...
University of Virginia School of Medicine scientists have obtained important new insights into how our bodies regulate our ...
After more than three decades of marriage, Don Dziadus made a life-changing commitment to his wife, Debbie. He donated his ...
Their results indicated that cMET activity was inhibited, which in turn lowered the cell growth signals. Not only that, but according to the paper, the treatment appears also to have triggered a ...
ST. PAUL, Minn., Nov. 6 (UPI) --Positive results from a late-stage clinical trial released Thursday have raised hopes that type 1 diabetes patients who suffer from chronic kidney disease will have a ...
The rising incidence of polycystic kidney disease (PKD) and other renal disorders continues to elevate demand for advanced treatment options. Increasing life expectancy and a growing elderly ...
The global Renal Cyst Treatment Market is on a trajectory of steady expansion, with its estimated value at USD 203.2 million in 2025, and forecasted to reach USD 331.0 million by 2035, reflecting a ...
A research effort led by scientists from the Keck School of Medicine at the University of Southern California (USC) has led to the development of more mature and complex lab-grown kidney progenitor ...
Autosomal dominant polycystic kidney disease (PKD) is a chronic and debilitating condition affecting over 12 million patients worldwide. PKD arises from mutations in the polycystin-1 (PC1) or PC2 ...
In an update to their guidelines for treating high blood pressure, a group of cardiovascular medical societies has included a new recommendation for adding renal denervation procedures as an option ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback